Keyphrases
Pulmonary Fibrosis
100%
Interleukin-23 (IL-23)
100%
Acute Exacerbation
100%
Interleukin-17 (IL-17)
25%
Cytokine Levels
16%
Bronchoalveolar Lavage Fluid
16%
Airway Inflammation
16%
Neutrophilic Inflammation
16%
Idiopathic Pulmonary Fibrosis
16%
Airway Fibrosis
16%
Wild Mice
8%
Gene-deficient Mice
8%
Inflammatory Cytokines
8%
Lung
8%
Airway
8%
T Helper 17 (Th17)
8%
Bleomycin
8%
Lipopolysaccharide
8%
Poor Prognosis
8%
Interleukin
8%
New Therapeutic Strategies
8%
Cell Cytokines
8%
Inflammatory Cells
8%
Morphometry
8%
AE-IPF
8%
Anti-interleukin-23
8%
Medicine and Dentistry
Pulmonary Fibrosis
100%
Interleukin 23
60%
Cytokine
30%
Interleukin 17
30%
Idiopathic Pulmonary Fibrosis
30%
Fibrosis
20%
Bronchoalveolar Lavage Fluid
20%
Respiratory Tract Inflammation
20%
Lipopolysaccharide
10%
Morphology
10%
Bleomycin
10%
Morphometrics
10%
Inflammatory Cell
10%
Interleukin 23p19
10%
Interleukin 23 Antibody
10%
Lung
10%
Immunology and Microbiology
Interleukin 23
100%
Airway
50%
Interleukin 17
50%
Cytokine
33%
Bronchoalveolar Lavage Fluid
33%
Wild Type Mouse
16%
Proinflammatory Cytokine
16%
Morphology
16%
Inflammatory Cell
16%
Interleukin 23 Subunit Alpha
16%
Interleukin 23 Antibody
16%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Fibrosis
100%
Interleukin 23
60%
Cytokine
30%
Interleukin 17
30%
Fibrosing Alveolitis
30%
Inflammation
20%
Fibrosis
20%
Respiratory Tract Inflammation
20%
Wild Type Mouse
10%
Bleomycin
10%
Lipopolysaccharide
10%
Interleukin 23p19
10%
Interleukin 23 Antibody
10%